These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 15071488

  • 1. Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus.
    Mugellini A, Preti P, Zoppi A, Corradi L, Fogari E, Derosa G, Fogari R.
    J Hum Hypertens; 2004 Oct; 18(10):687-91. PubMed ID: 15071488
    [Abstract] [Full Text] [Related]

  • 2. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
    Fogari R, Derosa G, Zoppi A, Rinaldi A, Preti P, Lazzari P, Mugellini A.
    Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
    [Abstract] [Full Text] [Related]

  • 3. Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria.
    Kohlmann O, Roca-Cusachs A, Laurent S, Schmieder RE, Wenzel RR, Fogari R.
    Adv Ther; 2009 Mar; 26(3):313-24. PubMed ID: 19330493
    [Abstract] [Full Text] [Related]

  • 4. Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.
    Fogari R, Derosa G, Zoppi A, Lazzari P, Corradi L, Preti P, Mugellini A.
    Intern Med; 2008 Mar; 47(5):361-6. PubMed ID: 18310964
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A, Schmieder RE, Triposkiadis F, Wenzel RR, Laurent S, Kohlmann O, Fogari R, MORE Study Group.
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 7. Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
    Fogari R, Mugellini A, Circelli M, Cremonesi G.
    Clin Drug Investig; 2011 Sep; 31(7):439-53. PubMed ID: 21627336
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
    Neutel JM.
    Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
    [Abstract] [Full Text] [Related]

  • 9. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.
    Coca A.
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):147-59. PubMed ID: 17338661
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
    Lewin AJ, Weir MR.
    Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
    [Abstract] [Full Text] [Related]

  • 11. Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study.
    Fogari R, Malamani G, Zoppi A, Mugellini A, Rinaldi A, Fogari E, Perrone T.
    Clin Ther; 2007 Mar; 29(3):413-8. PubMed ID: 17577462
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 13. Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
    Agabiti-Rosei E, Manolis A, Zava D, Omboni S, ZODIAC Study Group.
    Adv Ther; 2014 Feb; 31(2):217-33. PubMed ID: 24415271
    [Abstract] [Full Text] [Related]

  • 14. Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
    Fogari R, Corradi L, Zoppi A, Lazzari P, Mugellini A, Preti P, Rinaldi A.
    Am J Hypertens; 2007 Oct; 20(10):1092-6. PubMed ID: 17903693
    [Abstract] [Full Text] [Related]

  • 15. Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
    Fogari R, Preti P, Lazzari P, Corradi L, Zoppi A, Fogari E, Mugellini A.
    Eur J Clin Pharmacol; 2003 Aug; 59(4):271-5. PubMed ID: 12830340
    [Abstract] [Full Text] [Related]

  • 16. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
    Strutz F, Bramlage P, Paar WD.
    Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
    [Abstract] [Full Text] [Related]

  • 17. Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome).
    Napoli C, Omboni S, Borghi C, ZAMES (Zofenopril in Advanced MEtabolic Syndrome) Study Group.
    J Hypertens; 2016 Nov; 34(11):2287-97. PubMed ID: 27653164
    [Abstract] [Full Text] [Related]

  • 18. Delapril/manidipine.
    McCormack PL, Keating GM.
    Drugs; 2006 Nov; 66(7):961-9. PubMed ID: 16740017
    [Abstract] [Full Text] [Related]

  • 19. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial.
    Ruggenenti P, Lauria G, Iliev IP, Fassi A, Ilieva AP, Rota S, Chiurchiu C, Barlovic DP, Sghirlanzoni A, Lombardi R, Penza P, Cavaletti G, Piatti ML, Frigeni B, Filipponi M, Rubis N, Noris G, Motterlini N, Ene-Iordache B, Gaspari F, Perna A, Zaletel J, Bossi A, Dodesini AR, Trevisan R, Remuzzi G, DEMAND Study Investigators.
    Hypertension; 2011 Nov; 58(5):776-83. PubMed ID: 21931073
    [Abstract] [Full Text] [Related]

  • 20. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.